London · Delayed Price · Currency is GBP · Price in GBX Novacyt Company Description
Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmental sectors.
It operates through Yourgene Health and Primer Design segments. The Yourgene Health segment delivers molecular diagnostic and screening solutions, across reproductive health and precision medicine.
The Primer Design segment designs, manufactures, and markets molecular real-time qPCR testing devices and reagents in the areas of infectious diseases.
It operates in the United Kingdom, France, Europe, the United States, the Asia Pacific, the Middle East, and Africa.
The company was incorporated in 2006 and is based in Le Vésinet, France.
| Country | France |
| Founded | 2006 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 234 |
| CEO | Lyn Rees |
Contact Details
Address: 131 Boulevard Carnot Le Vésinet, 78110 France | |
| Phone | 33 1 39 46 51 04 |
| Website | novacyt.com |
Stock Details
| Ticker Symbol | NCYT |
| Exchange | London Stock Exchange AIM |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | GBP |
| ISIN Number | FR0010397232 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Lyn Rees | Chief Executive Officer |
| Steve Gibson | Chief Financial Officer |
| Peter Coyne | Chief Operating Officer |